Effects of Levamisole on Spontaneous Rosette-forming Cells in Murine Spleen
Overview
Authors
Affiliations
Levamisole, an anti-anergic chemotherapeutic agent, is shown to depress the azathioprine sensitivity of rosette-forming cells (RFC) in the spleen of normal mice, and to restore the azathioprine sensitivity of RFC in the spleen of adult thymectomized mice. Using the fully active dose of 1.25 mg/kg i.v., the restoration effect was present 15 h after treatment with the drug and almost disappeared after 48 h. Levamisole was ineffective on RFC in vitro. These results suggest that Levamisole might interfere with the reactivity of T lymphocytes as has been described for drugs interfering with cyclic nucleotide metabolism.
Thymopoietin and levamisole in chronic granulomatous inflammation.
Thrower P, Sedgwick A, Smith E, Willoughby D, Huskisson E Ann Rheum Dis. 1983; 42(1):94-7.
PMID: 6830330 PMC: 1001067. DOI: 10.1136/ard.42.1.94.
New approaches to immunotherapy: thymomimetic drugs.
Specter S, Hadden J Springer Semin Immunopathol. 1985; 8(4):375-85.
PMID: 3879015 DOI: 10.1007/BF01857391.
Verhaegen H, De Cock W, de Cree J Clin Exp Immunol. 1977; 29(2):311-5.
PMID: 908176 PMC: 1541083.
The effects of azathioprine and levamisole on lymphocyte stimulation.
Ivanyi L Clin Exp Immunol. 1979; 38(2):370-5.
PMID: 527269 PMC: 1537860.
Levamisole and human lymphocyte surface markers.
Wybran J, Govaerts A Clin Exp Immunol. 1977; 27(2):319-21.
PMID: 321166 PMC: 1540780.